99 related articles for article (PubMed ID: 19385660)
1. Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications.
Santo VE; Frias AM; Carida M; Cancedda R; Gomes ME; Mano JF; Reis RL
Biomacromolecules; 2009 Jun; 10(6):1392-401. PubMed ID: 19385660
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction.
Hao X; Silva EA; Månsson-Broberg A; Grinnemo KH; Siddiqui AJ; Dellgren G; Wärdell E; Brodin LA; Mooney DJ; Sylvén C
Cardiovasc Res; 2007 Jul; 75(1):178-85. PubMed ID: 17481597
[TBL] [Abstract][Full Text] [Related]
3. Sustained release of platelet-derived growth factor and vascular endothelial growth factor from silk/calcium phosphate/PLGA based nanocomposite scaffold.
Farokhi M; Mottaghitalab F; Ai J; Shokrgozar MA
Int J Pharm; 2013 Sep; 454(1):216-25. PubMed ID: 23856159
[TBL] [Abstract][Full Text] [Related]
4. Carrageenan based hydrogels for drug delivery, tissue engineering and wound healing.
Yegappan R; Selvaprithiviraj V; Amirthalingam S; Jayakumar R
Carbohydr Polym; 2018 Oct; 198():385-400. PubMed ID: 30093014
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Vascularization through the Controlled Release of Platelet-Derived Growth Factor-BB.
Minardi S; Pandolfi L; Taraballi F; Wang X; De Rosa E; Mills ZD; Liu X; Ferrari M; Tasciotti E
ACS Appl Mater Interfaces; 2017 May; 9(17):14566-14575. PubMed ID: 28393518
[TBL] [Abstract][Full Text] [Related]
6. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier.
Lee YM; Park YJ; Lee SJ; Ku Y; Han SB; Klokkevold PR; Chung CP
J Periodontol; 2000 Mar; 71(3):418-24. PubMed ID: 10776929
[TBL] [Abstract][Full Text] [Related]
7. Ionically cross-linked carrageenan-alginate hydrogel beads.
Mohamadnia Z; Zohuriaan-Mehr MJ; Kabiri K; Jamshidi A; Mobedi H
J Biomater Sci Polym Ed; 2008; 19(1):47-59. PubMed ID: 18177553
[TBL] [Abstract][Full Text] [Related]
8. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease.
Howell TH; Fiorellini JP; Paquette DW; Offenbacher S; Giannobile WV; Lynch SE
J Periodontol; 1997 Dec; 68(12):1186-93. PubMed ID: 9444594
[TBL] [Abstract][Full Text] [Related]
9. In situ synthesis of magnetic CaraPVA IPN nanocomposite hydrogels and controlled drug release.
Mahdavinia GR; Etemadi H
Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():250-60. PubMed ID: 25491827
[TBL] [Abstract][Full Text] [Related]
10. Controlled-release kinetics and biologic activity of platelet-derived growth factor-BB for use in flexor tendon repair.
Sakiyama-Elbert SE; Das R; Gelberman RH; Harwood F; Amiel D; Thomopoulos S
J Hand Surg Am; 2008 Nov; 33(9):1548-57. PubMed ID: 18984337
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of kappa carrageenan as potential carrier for floating drug delivery system: Effect of pore forming agents.
Selvakumaran S; Muhamad II; Abd Razak SI
Carbohydr Polym; 2016 Jan; 135():207-14. PubMed ID: 26453870
[TBL] [Abstract][Full Text] [Related]
12. Controlled delivery of platelet-derived growth factor-BB from injectable microsphere/hydrogel composites.
Wu H; Liu J; Wu J; Wan Y; Chen Y
Colloids Surf B Biointerfaces; 2016 Dec; 148():308-316. PubMed ID: 27619183
[TBL] [Abstract][Full Text] [Related]
13. Cell delivery systems using alginate--carrageenan hydrogel beads and fibers for regenerative medicine applications.
Popa EG; Gomes ME; Reis RL
Biomacromolecules; 2011 Nov; 12(11):3952-61. PubMed ID: 21970513
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies.
Jean M; Smaoui F; Lavertu M; Méthot S; Bouhdoud L; Buschmann MD; Merzouki A
Gene Ther; 2009 Sep; 16(9):1097-110. PubMed ID: 19440230
[TBL] [Abstract][Full Text] [Related]
15. PDGF-BB released in tendon repair using a novel delivery system promotes cell proliferation and collagen remodeling.
Thomopoulos S; Zaegel M; Das R; Harwood FL; Silva MJ; Amiel D; Sakiyama-Elbert S; Gelberman RH
J Orthop Res; 2007 Oct; 25(10):1358-68. PubMed ID: 17551975
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of endothelial cell-laden carrageenan microfibers for microvascularized bone tissue engineering applications.
Mihaila SM; Popa EG; Reis RL; Marques AP; Gomes ME
Biomacromolecules; 2014 Aug; 15(8):2849-60. PubMed ID: 24963559
[TBL] [Abstract][Full Text] [Related]
17. Starch-based microparticles as vehicles for the delivery of active platelet-derived growth factor.
Silva GA; Coutinho OP; Ducheyne P; Shapiro IM; Reis RL
Tissue Eng; 2007 Jun; 13(6):1259-68. PubMed ID: 17518721
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor-B gene delivery sustains gingival fibroblast signal transduction.
Lin Z; Sugai JV; Jin Q; Chandler LA; Giannobile WV
J Periodontal Res; 2008 Aug; 43(4):440-9. PubMed ID: 18823454
[TBL] [Abstract][Full Text] [Related]
20. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells.
van den Dolder J; Mooren R; Vloon AP; Stoelinga PJ; Jansen JA
Tissue Eng; 2006 Nov; 12(11):3067-73. PubMed ID: 17518622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
